DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aromasin (Exemestane) - Alopecia - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Alopecia (20)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Aromasin (Exemestane) where reactions include alopecia. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Aromasin side effects in female

Reported by a consumer/non-health professional from United States on 2012-08-01

Patient: female

Reactions: Alopecia, Liver Function Test Abnormal, Arthritis

Drug(s) suspected as cause:
Aromasin



Possible Aromasin side effects in 61 year old female

Reported by a consumer/non-health professional from France on 2012-07-10

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Folliculitis, Pain, Acne, Rash, Erythema, Skin Reaction, Hyperhidrosis, Weight Increased, Alopecia, Skin Lesion, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aromasin

Other drugs received by patient: Effexor XR; Prazepam



Possible Aromasin side effects in 61 year old female

Reported by a consumer/non-health professional from France on 2012-06-19

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Folliculitis, Acne, Pain, Rash, Erythema, Hyperhidrosis, Skin Reaction, Weight Increased, Alopecia, Skin Lesion, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aromasin

Other drugs received by patient: Effexor XR; Prazepam



Possible Aromasin side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-12

Patient: female

Reactions: Alopecia, Arthritis

Drug(s) suspected as cause:
Aromasin



Possible Aromasin side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-12

Patient: female, weighing 61.0 kg (134.2 pounds)

Reactions: Alopecia, Hypertension

Drug(s) suspected as cause:
Aromasin

Other drugs received by patient: Metoprolol; Atenolol



Possible Aromasin side effects in 61 year old female

Reported by a physician from France on 2012-06-12

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Folliculitis, Pain, Acne, Rash, Erythema, Hyperhidrosis, Skin Reaction, Weight Increased, Alopecia, Skin Lesion, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aromasin

Other drugs received by patient: Prazepam; Effexor XR



Possible Aromasin side effects in 61 year old female

Reported by a consumer/non-health professional from France on 2012-06-06

Patient: 61 year old female, weighing 70.0 kg (154.0 pounds)

Reactions: Pruritus, Acne, Pain, Folliculitis, Rash, Hyperhidrosis, Skin Reaction, Erythema, Weight Increased, Skin Lesion, Alopecia, Inflammation

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Aromasin

Other drugs received by patient: Effexor XR; Prazepam



Possible Aromasin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-20

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01



Possible Aromasin side effects in 43 year old female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-17

Patient: 43 year old female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Dosage: unk
    Start date: 2011-03-11
    End date: 2011-07-01

Tamoxifen Citrate
    Dosage: unk
    Administration route: Oral
    Start date: 2007-06-01
    End date: 2008-04-01

Aromasin
    Dosage: unk
    Administration route: Oral
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Dosage: unk
    Start date: 2006-11-17
    End date: 2007-01-05

Avastin
    Dosage: unk
    Start date: 2010-08-01
    End date: 2010-11-01

Epirubicin Hydrochloride
    Dosage: 100 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Femara
    Dosage: unk
    Administration route: Oral
    Start date: 2008-04-01
    End date: 2010-08-01

Cyclophosphamide
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-11-01
    End date: 2011-01-26

Fluorouracil
    Dosage: 500 mg, unk
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16

Xeloda
    Dosage: unk
    Administration route: Oral
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Dosage: unk
    Start date: 2010-03-26
    End date: 2010-07-16



Possible Aromasin side effects in female

Reported by a physician from France on 2012-04-13

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-04-01
    End date: 2010-08-01

Xeloda
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-11-01
    End date: 2011-01-01

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-03-11
    End date: 2011-07-01

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-08-01
    End date: 2010-11-01

Avastin
    Start date: 2010-11-01
    End date: 2011-01-26

Avastin
    Indication: Product Used FOR Unknown Indication
    Start date: 2010-03-26
    End date: 2010-07-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-15
    End date: 2006-10-27

Taxotere
    Dosage: 6 cycles
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-11-17
    End date: 2007-01-05

Taxotere
    Dosage: 6 cycles
    Start date: 2010-03-26
    End date: 2010-07-16



Possible Aromasin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-12

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Doxorubicin HCL
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27



Possible Aromasin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11

Patient: female

Reactions: Alopecia, Onycholysis

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Epirubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Femara
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-08-01

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-17
    End date: 2007-01-05

Cyclophosphamide
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Fluorouracil
    Indication: Breast Cancer
    Start date: 2006-09-15
    End date: 2006-10-27

Tamoxifen Citrate
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01



Possible Aromasin side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-04-11

Patient: female

Reactions: Lymphangitis, Alopecia, Onycholysis, Breast Cancer Recurrent

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Tamoxifen Citrate
    Indication: Breast Cancer
    Start date: 2007-06-01
    End date: 2008-04-01

Fluorouracil
    Indication: Breast Cancer

Taxotere
    Indication: Breast Cancer
    Start date: 2006-11-01
    End date: 2007-01-01

Avastin
    Indication: Breast Cancer
    Start date: 2010-03-26
    End date: 2011-01-26

Femara
    Dosage: unk ukn, unk
    Indication: Breast Cancer
    Start date: 2008-04-01
    End date: 2010-04-01

Cyclophosphamide
    Start date: 2006-09-15
    End date: 2006-10-27

Epirubicin Hydrochloride
    Indication: Breast Cancer

Xeloda
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-11-01
    End date: 2011-01-01

Doxorubicin Hydrochloride
    Indication: Breast Cancer
    Start date: 2011-03-11
    End date: 2011-07-01

Cyclophosphamide
    Start date: 2011-07-01

Taxotere
    Start date: 2010-03-26
    End date: 2010-07-16

Aromasin
    Administration route: Oral
    Indication: Breast Cancer
    Start date: 2010-08-01
    End date: 2010-11-01

Other drugs received by patient: Minoxidil; Doxorubicin HCL



Possible Aromasin side effects in female

Reported by a physician from France on 2012-04-10

Patient: female

Reactions: Alopecia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Taxotere
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-10-22
    End date: 2007-12-03

Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-02-11
    End date: 2009-01-16

Herceptin
    Start date: 2010-12-01

Paclitaxel
    Start date: 2011-02-08
    End date: 2011-05-24

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-01
    End date: 2011-01-01

Paclitaxel
    Dosage: drug: paclitaxel ebewe
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-10
    End date: 2011-02-01

Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Cyclophosphamide
    Dosage: drug: paclitaxel hospira
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Arimidex
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-03-01



Possible Aromasin side effects in female

Reported by a physician from France on 2012-03-23

Patient: female

Reactions: Alopecia

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-02-11
    End date: 2009-01-16

Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Cyclophosphamide
    Dosage: drug: paclitaxel hospira
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-08-20
    End date: 2007-10-01

Paclitaxel
    Dosage: drug: paclitaxel ebewe
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-01-10
    End date: 2011-02-01

Arimidex
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-03-01

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-09-01
    End date: 2011-01-01

Herceptin
    Start date: 2010-12-01

Taxotere
    Indication: Product Used FOR Unknown Indication
    Start date: 2007-10-22
    End date: 2007-12-03

Paclitaxel
    Start date: 2011-02-08
    End date: 2011-05-24



Possible Aromasin side effects in female

Reported by a consumer/non-health professional from United States on 2012-03-05

Patient: female

Reactions: Weight Increased, Anxiety, Fatigue, Arthralgia, Alopecia, Pain, Depression

Drug(s) suspected as cause:
Aromasin



Possible Aromasin side effects in female

Reported by a consumer/non-health professional from United States on 2011-12-13

Patient: female, weighing 81.6 kg (179.6 pounds)

Reactions: Abdominal Pain, LIP Blister, Alopecia, Oral Herpes

Drug(s) suspected as cause:
Zocor
    Indication: Blood Cholesterol Abnormal

Zocor
    Dosage: 20 mg, unk
    Indication: Cardiovascular Event Prophylaxis

Aromasin
    Dosage: 25 mg, daily
    Administration route: Oral
    Indication: Neoplasm Prophylaxis
    Start date: 2011-06-01
    End date: 2011-11-01

Other drugs received by patient: Fish OIL; Atenolol; Acetylsalicylic Acid



Possible Aromasin side effects in 55 year old female

Reported by a physician from United Kingdom on 2011-11-11

Patient: 55 year old female

Reactions: Alopecia

Drug(s) suspected as cause:
Aromasin



Possible Aromasin side effects in 65 year old female

Reported by a consumer/non-health professional from India on 2011-10-26

Patient: 65 year old female

Reactions: Aphasia, Pyrexia, Encephalitis Viral, Oropharyngeal Pain, Constipation, Convulsion, Malaise, Limb Discomfort, Insomnia, Alopecia, Depression, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Aromasin



Possible Aromasin side effects in female

Reported by a physician from France on 2011-10-14

Patient: female

Reactions: Alopecia

Drug(s) suspected as cause:
Fluorouracil
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-03-03
    End date: 2006-06-19

Epirubicin Hydrochloride
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-03-03
    End date: 2006-06-19

Aromasin
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-01
    End date: 2011-09-01

Herceptin
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-09-11
    End date: 2007-07-03

Cyclophosphamide
    Indication: Product Used FOR Unknown Indication
    Start date: 2006-03-03
    End date: 2006-06-19

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017